MK-5204

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameMK-5204
Drug Alias NameMK-5204
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action1,3-beta-glucan synthase inhibitors
Targets1,3-beta-glucan synthase
Therapy Area/IndicationsCandidiasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck & CoScynexis Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & CoScynexis Inc
Inactive CompaniesN/A
Active IndicationsCandidiasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A